These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27322865)

  • 1. Ampicillin- and ampicillin/sulbactam-resistant Escherichia coli infection in a neonatal intensive care unit in Japan.
    Saida K; Ito Y; Shima Y; Kasuga E; Kusakari M; Miyosawa Y; Baba A
    Pediatr Int; 2016 Jun; 58(6):537-9. PubMed ID: 27322865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic and clinical studies on sulbactam/ampicillin in children].
    Hattori K; Higashino H; Kobayashi T; Yamamoto C; Nobori U; Nakamura Y; Satou Y; Kurokawa H; Nogi S; Kobayashi Y
    Jpn J Antibiot; 1989 Mar; 42(3):701-17. PubMed ID: 2746850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on sulbactam/ampicillin in the field of pediatrics].
    Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
    Jpn J Antibiot; 1989 Mar; 42(3):662-74. PubMed ID: 2664250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients].
    Motohiro T; Sakata Y; Oda K; Aramaki M; Tanaka K; Koga T; Shimada Y; Fujimoto T; Yamashita F; Sakamoto H
    Jpn J Antibiot; 1989 Mar; 42(3):773-90. PubMed ID: 2664252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic, bacteriological and clinical evaluation of sulbactam/ampicillin in pediatrics].
    Hayashi M; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1989 Mar; 42(3):743-53. PubMed ID: 2746854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of sulbactam/ampicillin in children].
    Ito S; Mayumi M; Ito M; Mikawa H
    Jpn J Antibiot; 1989 Mar; 42(3):675-85. PubMed ID: 2664251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of sulbactam/ampicillin in the field of pediatrics].
    Ogura H; Hisakawa H; Kawakubo K; Kubota H; Shimanouchi Y; Matsumoto K; Tomoda T; Tone Y; Kurashige T
    Jpn J Antibiot; 1989 Mar; 42(3):766-72. PubMed ID: 2746856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic and clinical studies of sultamicillin granule in the pediatric field].
    Motohiro T; Sakata Y; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Yamashita F; Takajo N
    Jpn J Antibiot; 1988 Dec; 41(12):1980-2000. PubMed ID: 3249372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial.
    Hamao N; Ito I; Konishi S; Tanabe N; Shirata M; Oi I; Tsukino M; Matsumoto H; Yasutomo Y; Kadowaki S; Hirai T
    BMC Pulm Med; 2020 Jun; 20(1):160. PubMed ID: 32503515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic and bacteriological studies on sulbactam/ampicillin in the field of pediatrics].
    Sato Y; Ishikawa K; Iwata S; Akita H; Oikawa T; Sunakawa K
    Jpn J Antibiot; 1989 Mar; 42(3):579-93. PubMed ID: 2746843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic, bacteriological and clinical studies on sulbactam/ampicillin in pediatric field].
    Nakao Y; Kimura H; Miura K; Miyajima Y; Ishikawa H; Hayakawa F; Kuno K
    Jpn J Antibiot; 1989 Mar; 42(3):639-50. PubMed ID: 2746847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patients.
    Kaye KS; Harris AD; Gold H; Carmeli Y
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1004-9. PubMed ID: 10722504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic and clinical studies on sulbactam/ampicillin in the pediatric field].
    Yanagishima M; Yanai M; Yanagi T; Tsuji Y; Nakayama N; Imamura H
    Jpn J Antibiot; 1989 Mar; 42(3):754-65. PubMed ID: 2746855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laboratory and clinical studies of sulbactam/ampicillin in pediatric field].
    Nishimura T; Tabuki K; Aoki S; Sugita K; Takagi M
    Jpn J Antibiot; 1989 Mar; 42(3):687-700. PubMed ID: 2746849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimicrobial activities of sulbactam/ampicillin against clinically isolated microbial strains].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 Apr; 48(4):529-47. PubMed ID: 7783316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The efficacy of prophylactic administration of SBT/ABPC for postoperative infection in neurosurgical operations].
    Idomari K; Sakai K; Takasawa H; Miyairi Y; Yako T; Murata T; Sakamoto M; Nitta J; Hongo K; Kobayashi S; Aoki T; Kobayashi S
    No Shinkei Geka; 2002 Oct; 30(10):1075-80. PubMed ID: 12404767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteriological, pharmacokinetic and clinical studies of sulbactam/ampicillin in the pediatric field].
    Haruta T; Kuroki S; Okura K; Yoshioka N; Yamaoka K; Hashimoto H; Kobayashi Y
    Jpn J Antibiot; 1989 Mar; 42(3):719-24. PubMed ID: 2746851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ampicillin/sulbactam versus cefazolin plus aminoglycosides for antimicrobial prophylaxis in management of Gustilo type IIIA open fractures: A retrospective cohort study.
    Takahara S; Tokura T; Nishida R; Uefuji A; Ichimura K; Nishihara H; Aoki K; Takayama H; Nakagawa N; Harada T
    Injury; 2022 Apr; 53(4):1517-1522. PubMed ID: 35090733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II, multicenter, nonblinded, randomized controlled trial for evaluating protective effects of ABPC/SBT plus, azithromycin versus erythromycin, in pregnant women with pPROM occurring at <28 weeks of gestation on the development of BPD in neonates: Study protocol.
    Ohkuchi A; Okazaki K; Iwamoto S; Sako M; Kobayashi T; Yanagihara I; Nomiyama M;
    PLoS One; 2024; 19(7):e0304705. PubMed ID: 38980858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: a multicenter, open-label, uncontrolled study.
    Kohno S; Tateda K; Mikamo H; Kadota J; Niki Y; Itamura R
    J Infect Chemother; 2015 Mar; 21(3):182-8. PubMed ID: 25533886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.